ProteqFlu Tetanus DOI Announcement

Merial Animal Health is pleased to announce that the duration of immunity for the tetanus component of PROTEQFLU-Te® has been extended to 2 years. Commenting on the news, Merial’s Veterinary Technical Manager Kevin Whelan said “This is a welcome new addition to the label claims for this advanced vaccine, which is the only equine flu vaccine in the UK to contain a recently updated influenza virus strain. The updated strain, innovative canarypox vector technology and now the extended tetanus DOI claim make the vaccine an excellent choice for vets in the UK” PROTEQFLU-Te can now be used on an alternate year basis in combination with Merial’s other flu vaccine, PROTEQFLU, which does not contain tetanus toxoid. The one year duration of immunity for the influenza component remains unchanged. Please contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards